Key result
Post-aSAH acute coronary syndrome is linked to ~3.4-fold higher odds of unfavorable 6-month neurological outcomes.
Why the study?
Development of acute coronary syndrome after aneurysmal subarachnoid hemorrhage strongly affects further neuro-intensive care management, but its incidence, risk factors, and clinical impact required analysis.
Can a risk score based on routine admission variables reliably predict the development of acute coronary syndrome in patients with aneurysmal subarachnoid hemorrhage?
Cohort (n=855)
No
Can a risk score based on routine admission variables reliably predict the development of acute coronary syndrome in patients with aneurysmal subarachnoid hemorrhage?
Odds Ratio: 3.43
Absolute Event Rate: 66.7% vs 36.4%
p-value: p=0.027
A novel 10-point risk score based on five routine admission parameters can reliably predict the development of acute coronary syndrome in patients with aneurysmal subarachnoid hemorrhage, allowing for targeted preventive cardiac monitoring.
Background and Objectives: Development of acute coronary syndrome (ACS) after aneurysmal subarachnoid hemorrhage (aSAH) strongly affects further neuro-intensive care management. We aimed to analyze the incidence, risk factors and clinical impact of ACS in aSAH patients. Materials and Methods: This retrospective analysis included 855 aSAH cases treated between 01/2003 and 06/2016. The occurrence of ACS during 3 weeks of aSAH was documented. Patients’ demographic, clinical, radiographic and laboratory characteristics at admission were collected as potential ACS predictors. The association between ACS and the aSAH outcome was analyzed as the occurrence of cerebral infarcts in the computed tomography scans and unfavorable outcome (modified Rankin scale > 3) at 6 months after aSAH. Univariable and multivariable analyses were performed. Results: ACS was documented in 28 cases (3.3%) in the final cohort (mean age: 54.9 years; 67.8% females). In the multivariable analysis, there was a significant association between ACS, an unfavorable outcome (adjusted odds ratio [aOR] = 3.43, p = 0.027) and a borderline significance with cerebral infarcts (aOR = 2.5, p = 0.066). The final prediction model for ACS occurrence included five independent predictors (age > 55 years [1 point], serum sodium < 142 mmol/L [3 points], blood sugar ≥ 170 mg/dL [2 points], serum creatine kinase ≥ 255 U/L [3 points] and gamma-glutamyl transferase ≥ 36 U/L [1 point]) and showed high diagnostic accuracy for ACS prediction (AUC = 0.879). Depending on the cumulative score value, the risk of ACS in the cohort varied between 0% (0 points) and 66.7% (10 points). Conclusions: ACS is a rare, but clinically very relevant, complication of aSAH. The development of ACS can reliably be predicted by the presented prediction model, which enables the early identification of aSAH individuals at high risk for ACS. External validation of the prediction model is mandatory.
No takes yet. Share an insight, caveat, or question.
Meška et al. (2024) conducted a cohort in Aneurysmal subarachnoid hemorrhage (n=855). Acute Coronary Syndrome vs. No Acute Coronary Syndrome was evaluated on Unfavorable outcome (modified Rankin scale > 3) at 6 months (aOR 3.43, p=0.027). The development of acute coronary syndrome after aneurysmal subarachnoid hemorrhage was independently associated with a significantly higher risk of an unfavorable neurological outcome at 6 months (aOR 3.43, p=0.027).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: